AI-assisted Predictive Model for Dialysis Outcomes
AI-assisted Predictive Model for Dialysis Outcomes: This study utilizes an AI-assisted predictive model that analyzes multimodal data from electronic health records, including medical history, laboratory results, dialysis treatment details, and clinical observations, to predict outcomes for dialysis patients. The model employs deep learning algorithms to predict mortality risk, intermediate outcomes such as anemia, blood pressure control, nutrition, and calcium-phosphate metabolism, and helps identify early signs of deterioration. The intervention is not a direct treatment or procedure but aims to develop a tool for predicting patient outcomes and optimizing treatment strategies to improve overall health and survival rates for dialysis patients.
Study summary
This is a multi-center, clinical study designed to evaluate the application and effectiveness of an AI-assisted predictive model for outcome of dialysis patients, leveraging multimodal health data.
Eligibility
Sex
ALL
Min age
20 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria:
1. Patients who have been undergoing dialysis (either hemodialysis or peritoneal dialysis) for at least 3 months.
2. Complete and accessible EHR data, including medical history, laboratory test results, dialysis treatment details, and clinical observations.
3. Participants must provide informed consent for the use of their health data for research purposes.
Exclusion Criteria:
1. Patients with incomplete or missing critical EHR data, including medical history, laboratory results, dialysis data, or treatment details necessary for the study.
2. Patients who have been on dialysis for less than 3 months, to ensure stable data for outcome prediction.
Primary outcome measure(s)
Mortality Prediction Accuracy — 1 year The ability of the AI-assisted predictive model to accurately predict the risk of mortality in dialysis patients. Prediction accuracy will be assessed using the Area Under the Curve (AUC), F1 score, and sensitivity/specificity. The model will be evaluated by comparing the predicted mortality risk with actual outcomes (i.e., whether patients survived or passed away during the study period).
Trial sites (1)
Facility
City
Region
Status
General Hospital of PLA
Beijing
Beijing Municipality
Recruiting
More The Eye Hospital of Wenzhou Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.